Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 5202 Reports

🤖 AI Analyzed

Recent

📄 Page 54 of 434

NewHydrogen, Inc.

10-K March 30, 2026

Key Highlights

Developing ThermoLoop™ technology to produce green hydrogen using heat instead o...
Targeting a production cost of under $1.00 per kilogram for green hydrogen.
Business model focused on licensing technology to large manufacturers to minimiz...

Read Analysis

🤖 AI Generated

CareView Communications Inc

10-K March 30, 2026

Key Highlights

Transitioned to a sales-based model, driving a 232% increase in sales-based cont...
Achieved positive cash flow from operations of $805,000 in 2025.
Secured strategic pre-approval agreements with major hospital networks like Heal...

Read Analysis

🤖 AI Generated

Domtar CORP

10-K March 30, 2026

Key Highlights

Strategic shift toward high-margin specialty products and recycled packaging to ...
Aggressive debt reduction strategy, raising over $200 million through non-core a...
High operational self-sufficiency, generating 75% of power from wood by-product ...

Read Analysis

🤖 AI Generated

Scienture Holdings, Inc.

10-K March 30, 2026

Key Highlights

Successful FDA approval and launch of SCN-102 in 2025.
Strategic pivot to a pure-play drug development model after exiting food tech.
Three additional drug candidates in the pipeline with market entry targeted for ...

Read Analysis

🤖 AI Generated

Actinium Pharmaceuticals, Inc.

10-K March 30, 2026

Key Highlights

Lead candidate Iomab-B addresses a significant market gap in bone marrow transpl...
ATNM-400 shows potential to outperform current cancer treatments by 3–5 times in...
The company is strategically positioning itself as an acquisition target for maj...

Read Analysis

🤖 AI Generated

DiaMedica Therapeutics Inc.

10-K March 30, 2026

Key Highlights

Advancing DM199, a synthetic KLK1 protein, for stroke, preeclampsia, and fetal g...
Positive clinical results from a preeclampsia study in South Africa showing safe...
Adaptive design for the ReMEDy2 stroke trial allows for early stopping to preser...

Read Analysis

🤖 AI Generated

Fifth Third Holdings Funding, LLC

10-K March 30, 2026

Key Highlights

Issued $1.2 billion in asset-backed securities in 2023.
Maintained a low net loss rate of less than 0.85% on the loan portfolio.
Strong credit enhancement through a $6.2 million reserve account and overcollate...

Read Analysis

🤖 AI Generated

LINGERIE FIGHTING CHAMPIONSHIPS, INC.

10-K March 30, 2026

Key Highlights

Strong digital footprint with over 800,000 YouTube subscribers and 250 million v...
Lean production model utilizes contractors to keep operational costs low.
Diversified revenue streams including international licensing, merchandise, and ...

Read Analysis

🤖 AI Generated

Kraig Biocraft Laboratories, Inc.

10-K March 30, 2026

Key Highlights

Pioneering genetic engineering to produce high-performance hybrid spider silk.
Strategic shift toward commercial production in Vietnam using a low-cost 'plug a...
Strong intellectual property portfolio including over 10 patents and proprietary...

Read Analysis

🤖 AI Generated

Osisko Development Corp.

40-F March 30, 2026

Key Highlights

Flagship Cariboo Gold Project development is the primary growth driver.
Secured a $100 million credit line to fund operations through 2026.
Streamlined portfolio by selling the San Antonio Gold Project for $30 million.

Read Analysis

🤖 AI Generated

Lightstone Value Plus REIT II, Inc.

10-K March 30, 2026

Key Highlights

REIT structure mandates payout of 90% of taxable income to shareholders
Portfolio consists of diversified hotel and retail shopping center assets
Company maintains a clear exit strategy focused on asset sales rather than publi...

Read Analysis

🤖 AI Generated

AIxCrypto Holdings, Inc.

10-K March 30, 2026

Key Highlights

Strategic pivot from drug development to RWA tokenization and Embodied AI.
Development of a 'Dual Flywheel' model to automate asset tokenization using AI.
Upcoming launch of 'Agent-Pay' tools scheduled for Q3 2026.

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage